NLRC5 and nasopharyngeal carcinoma: From the results so far, P4 treatment of EBV+ NPC cells leads to the expression of LMP1, which in turn triggered the expression of IFN-γ and p-JNK to drive NLRC5 induction of BTN3A1 and BTN2A1.